EUVIMEDScopri EUVIMED
Crossref

HSP90β shapes the fate of Th17 cells with the help of glycolysis‐controlled methylation modification

Ling Yang, Jing-Chao Zhu, Shi-Jia Li, Xi Zeng, Xin-Ru Xue, Yue Dai, Zhi-Feng Wei iD

British Journal of Pharmacology · 2024

DOI: 10.1111/bph.16432 ↗

At a glance

Journal article in British Journal of Pharmacology, 2024. Written by Ling Yang and 6 co-authors. Institution: Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China. Major MEDLINE topics: Th17 Cells, Glycolysis, HSP90 Heat-Shock Proteins, Mice, Inbred C57BL. Cited 11 times so far (Crossref); 62 references. Funded by: "Double First-Class" University Project, Priority Academic Program Development of Jiangsu Higher Education Institutions, Project 211.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background and Purpose Ulcerative colitis (UC) is a refractory inflammatory disease associated with immune dysregulation. Elevated levels of heat shock protein (HSP) 90 in the β but not α subtype were positively associated with disease status in UC patients. This study validated the possibility that pharmacological inhibition or reduction of HSP90β would alleviate colitis, induced by dextran sulfate sodium, in mice and elucidated its mechanisms. Experimental Approach Histopathological and biochemical analysis assessed disease severity, and bioinformatics and correlation analysis explained the association between the many immune cells and HSP90β. Flow cytometry was used to analyse the homeostasis and transdifferentiation of Th17 and Treg cells. In vitro inhibition and adoptive transfer assays were used to investigate functions of the phenotypically transformed Th17 cells. Metabolomic analysis, DNA methylation detection and chromatin immunoprecipitation were used to explore these mechanisms. Key Results The selective pharmacological inhibitor (HSP90βi) and shHSP90β significantly mitigated UC in mice and promoted transformation of Th17 to Treg cell phenotype, via Foxp3 transcription. The phenotypically‐transformed Th17 cells by HSP90βi or shHSP90β were able to inhibit lymphocyte proliferation and colitis in mice. HSP90βi and shHSP90β selectively weakened glycolysis by stopping the direct association of HSP90β and GLUT1, the key glucose transporter, to accelerate ubiquitination degradation of GLUT1, and enhance the methylation of Foxp3 CNS2 region. Then, the mediator path was identified as the “lactate‐STAT5‐TET2” cascade. Conclusion and Implications HSP90β shapes the fate of Th17 cells via glycolysis‐controlled methylation modification to affect UC progression, which provides a new therapeutic target for UC.

Subjects

MeSH terms (MEDLINE)

Th17 CellsGlycolysisHSP90 Heat-Shock ProteinsMice, Inbred C57BLAnimalsMiceMaleDNA MethylationDextran SulfateColitis, UlcerativeT-Lymphocytes, RegulatoryHumans

Author keywords

DNA methylationHSP90βglycolysistrans‐differentiation of Th17 cellsulcerative colitis

Substances

HSP90 Heat-Shock ProteinsDextran Sulfate

Authors and institutions

  • Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, China.

ORCID profiles: Zhi-Feng Wei

Funding

  • "Double First-Class" University Project
  • Priority Academic Program Development of Jiangsu Higher Education Institutions
  • Project 211

Cite

APA

Yang, L., Zhu, J. C., Li, S. J., Zeng, X., Xue, X. R., Dai, Y., & Wei, Z. F. (2024). HSP90β shapes the fate of Th17 cells with the help of glycolysis‐controlled methylation modification. British Journal of Pharmacology. https://doi.org/10.1111/bph.16432

Vancouver

Yang L, Zhu JC, Li SJ, Zeng X, Xue XR, Dai Y, et al. HSP90β shapes the fate of Th17 cells with the help of glycolysis‐controlled methylation modification. British Journal of Pharmacology. 2024. doi:10.1111/bph.16432

BibTeX
@article{Yang2024,
  author = {Yang, Ling and Zhu, Jing-Chao and Li, Shi-Jia and Zeng, Xi and Xue, Xin-Ru and Dai, Yue and Wei, Zhi-Feng},
  title = {HSP90β shapes the fate of Th17 cells with the help of glycolysis‐controlled methylation modification},
  journal = {British Journal of Pharmacology},
  year = {2024},
  doi = {10.1111/bph.16432}
}
Start for free →